Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.11
Delayed Data
As of Aug 04
 -0.03 / -0.37%
Today’s Change
6.76
Today|||52-Week Range
16.87
-33.80%
Year-to-Date

Today’s Trading

Previous close8.14
Today’s open8.12
Day’s range8.05 - 8.26
Volume1,970,356
Average volume (3 months)3,157,681
Market cap$1.0B
Dividend yield--
Data as of 08/04/2015

Growth & Valuation

Earnings growth (last year)-11.11%
Earnings growth (this year)+13.38%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.15

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.16+0.76%
DVAXDynavax Technologies...0.000.00%
ITCIIntra-Cellular Thera...-0.40-1.35%
ZFGNZafgen Inc-0.30-0.79%
Data as of 08/04/2015

Financials

Last reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$69.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts